With an increase of one percent over the past five weeks for the week ended April 18, 2008, the G-2 Laboratory Stock Index rebounded slightly after months of posting losses. But the economic downturn continues to impact the Nasdaq and the S&P 500 this year, although both are down less than they were in March. The Nasdaq is down 10.15 percent and the S&P 500 is down 5.96 percent so far in 2008.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

May 2008 - Table of Contents

LIR May 2008 (full PDF issue)

Injunction in Hand, Industry Focuses on Repealing Competitive Bidding Demo

Medicare Part B Lab Spending Inches Up 1.6% to $6.8B

Future of Carilion Labs in Question

AmeriPath Helps Boost Quest’s Q1 Revenues Up 16.9% to $1.8B Over Prior Year

Global Lab M&A Market Totaled $38M in Q1 2008

Lab Industry Celebrates Temporary Injunction as Fight Continues to Repeal Competitive Bidding Demo

Denver’s National Jewish Medical Opens $1 Million+ Molecular Dx Lab

Pathologists Fight United Healthcare for Nonpayment in Class Action Suit

Third Wave Teams With DCL Medical Labs for Molecular Dx Partnership

Lab Stocks Post Slight Rebound in April; Index Up 1% Over 5 Weeks

Hawaii Enlists Regional Labs to Expand Flu Testing